Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826991 · ClinicalTrials.gov registry record · NA
Wells and Enteric Disease Transmission
A NA study of Diarrhea and Respiratory Viral Infection, sponsored by Temple University.
- Active
- Registry status
- NA
- Development phase
- 908
- Enrollment target
- 1
- Study location
NCT04826991 is a NA study of Diarrhea and Respiratory Viral Infection that is active but no longer recruiting, run by Temple University. The registered enrollment target is 908 participants, above the 119-participant average among 24 other Diarrhea trials with a reported enrollment target (663% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04826991, a NA study of Diarrhea and Respiratory Viral Infection, is active but no longer recruiting, sponsored by Temple University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 908 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 40 million people in the US are served by private, and frequently untreated, wells. Our best estimate is that 1.3 million cases of gastrointestinal illnesses (GI) per year are attributed to consuming water from untreated private wells in the US, but in reality, there are no robust epidemiological data that can be used to estimate cases of GI attributable to these sources. We propose the first randomized controlled trial (RCT) to estimate the burden of GI associated with private well water. We will test if household treatment of private well water by ultraviolet light (UV) vs. sham (inactive UV device) decreases the incidence of GI in children under 5. We will also examine the presence of viral, bacterial, and protozoan pathogens in stool and well water from participants. These data will fill a knowledge gap on sporadic GI associated with federally-unregulated private water supplies in the US.
Conditions Studied
Interventions
- DEVICE Active UV Device
- DEVICE Inactive UV Device
Study Locations (1)
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 908 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04826991
The ClinicalTrials.gov registry entry for NCT04826991 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 908 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 24 other Diarrhea trials with a reported enrollment target (663% higher). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diarrhea appearing as the primary indexed condition, and to 2 interventions - of which Active UV Device is the first listed.
NCT04826991 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04826991 about?
NCT04826991 is a clinical study titled "Wells and Enteric Disease Transmission". Approximately 40 million people in the US are served by private, and frequently untreated, wells. Our best estimate is that 1.3 million cases of gastrointestinal illnesses (GI) per year are attributed to consuming water from untreated private wells in the US, but in reality, there are no robust epid...
What is the current status of trial NCT04826991?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 908 participants. The study started on 2021-07-01. Estimated completion is 2027-08-31.
What conditions does trial NCT04826991 study?
This clinical trial studies the following conditions: Diarrhea, Respiratory Viral Infection, Gastrointestinal Infection, Waterborne Diseases.
What interventions are being tested in trial NCT04826991?
The interventions under investigation include: Active UV Device (DEVICE), Inactive UV Device (DEVICE).
Who is sponsoring clinical trial NCT04826991?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04826991 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diarrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GI Alpha-Gal Study
RECRUITING · NA
-
A Trial of Tap Water Treatment in the Elderly
COMPLETED · NA
-
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
COMPLETED · NA
-
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
COMPLETED · NA
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.